* Executive Ludovic Helfgott tells Reuters $3.5 billion
sales goal for Brilinta no longer attainable
Further company coverage:
(Reporting by UK bureau)
The post BRIEF-AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable appeared first on NASDAQ.